Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -312.63% is 19% above its 5-year average of -384.98%, around the middle of its 5-year range (-3239.97%–1524.26%).
45.73% above its 12-month average of -576.03%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -773.24%.
NET PROFIT MARGIN
-312.63%
NET PROFIT MARGIN AVG TTM
-576.03%
NET PROFIT MARGIN AVG 3Y
-384.16%
NET PROFIT MARGIN AVG 5Y
-384.98%
NET PROFIT MARGIN AVG 10Y
-561.73%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+45.73%
CURRENT VS 3Y AVG
+18.62%
CURRENT VS 5Y AVG
+18.79%
CURRENT VS 10Y AVG
+44.34%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-120142.31%
vs the sector median at left
Voyager Therapeutics, Inc.
Market Cap
$148.64M
Net Profit Margin
-312.63%
TTM Avg
-576.03%
3Y Avg
-384.16%
5Y Avg
-384.98%
Market Cap
$148.73M
Net Profit Margin
-353.00%
TTM Avg
-161.48%
3Y Avg
-3791.01%
5Y Avg
-3351.38%
Market Cap
$148.27M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$149.36M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-644.95%
Market Cap
$146.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-85.02%
Market Cap
$146.28M
Net Profit Margin
-39.55%
TTM Avg
-86.23%
3Y Avg
-76.35%
5Y Avg
-60.08%
Market Cap
$146.27M
Net Profit Margin
163.32%
TTM Avg
-34.49%
3Y Avg
-63.76%
5Y Avg
-75.19%
Market Cap
$151.01M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-6695.15%
Market Cap
$152.72M
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | $148.64M | -312.63% | -576.03% | -384.16% | -384.98% |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | -353.00% | -161.48% | -3791.01% | -3351.38% |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | 0.00% | 0.00% | 0.00% | -644.95% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | 0.00% | 0.00% | 0.00% | -85.02% |
| Codexis, Inc. (CDXS)vs › | $146.28M | -39.55% | -86.23% | -76.35% | -60.08% |
| Fortress Biotech, Inc. (FBIOP)vs › | $146.27M | 163.32% | -34.49% | -63.76% | -75.19% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | 0.00% | 0.00% | 0.00% | -6695.15% |
| Veraxa Biotech Holding AG (VRXA)vs › | $152.72M | N/A | N/A | N/A | N/A |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-326.6%
Net Profit Margin
-312.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -773.24% |
| 2026-03-31 | -1077.40% |
| 2025-12-31 | -178.83% |
| 2025-09-30 | -208.69% |
| 2025-06-30 | -641.96% |
| 2025-03-31 | -479.24% |
| 2024-12-31 | -549.33% |
| 2024-09-30 | -36.72% |
| 2024-06-30 | -34.29% |
| 2024-03-31 | -58.05% |
| 2023-12-31 | 62.62% |
| 2023-09-30 | -561.36% |
| 2023-06-30 | -457.61% |
| 2023-03-31 | 82.43% |
| 2022-12-31 | 1524.26% |
| 2022-09-30 | 42.90% |
| 2022-06-30 | -2680.76% |
| 2022-03-31 | -3239.97% |
| 2021-12-31 | 20.34% |
| 2021-09-30 | -1696.15% |
| 2021-06-30 | -2219.60% |
| 2021-03-31 | -333.01% |
| 2020-12-31 | -243.63% |
| 2020-09-30 | 72.65% |
| 2020-06-30 | -30.27% |
| 2020-03-31 | -134.29% |
| 2019-12-31 | -38.48% |
| 2019-09-30 | -73.44% |
| 2019-06-30 | 24.20% |
| 2019-03-31 | -522.80% |
| 2018-12-31 | -1122.11% |
| 2018-09-30 | -968.91% |
| 2018-06-30 | -991.88% |
| 2018-03-31 | -2115.29% |
| 2017-12-31 | -185.45% |
| 2017-09-30 | -2033.62% |
| 2017-06-30 | -1603.74% |
| 2017-03-31 | -1137.16% |
| 2016-12-31 | -621.25% |
| 2016-09-30 | -271.95% |
| 2016-06-30 | -250.94% |
| 2016-03-31 | -148.82% |
| 2015-12-31 | -147.52% |
| 2015-09-30 | -79.34% |
| 2015-06-30 | -79.75% |
| 2015-03-31 | -565.88% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
